» Authors » Kawthar Bouchemal

Kawthar Bouchemal

Explore the profile of Kawthar Bouchemal including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 65
Citations 661
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Hadji H, Cailleau C, Chassaing B, Bourge M, Ponchel G, Bouchemal K
Biomater Sci . 2024 Oct; 12(22):5812-5823. PMID: 39405189
The physicochemical properties of colloidal particles-such as size, surface properties, and morphology-play a crucial role in determining their behaviors and transit through the gastrointestinal (GI) tract. While some data exist...
2.
Sumohan Pillai A, Achraf Ben Njima M, Ayadi Y, Cattiaux L, Ladram A, Piesse C, et al.
Int J Pharm . 2024 Jun; 660:124379. PMID: 38925235
Nanogels are aqueous dispersions of hydrogel particles formed by physically or chemically cross-linked polymer networks of nanoscale size. Herein, we devised a straightforward technique to fabricate a novel class of...
3.
Suphaphiphat K, Desjardins D, Lorin V, Dimant N, Bouchemal K, Bossevot L, et al.
Nat Commun . 2023 Oct; 14(1):6224. PMID: 37803011
Passive immunization using broadly neutralizing antibodies (bNAbs) is investigated in clinical settings to inhibit HIV-1 acquisition due to the lack of a preventive vaccine. However, bNAbs efficacy against highly infectious...
4.
Diaz-Salmeron R, Cailleau C, Denis S, Ponchel G, Bouchemal K
J Control Release . 2023 Mar; 356:434-447. PMID: 36921722
Glycosaminoglycan (GAG) replenishment therapy consists of the instillation of GAG solutions directly in the bladder to alleviate Bladder Painful Syndrome/Interstitial Cystitis (BPS/IC). However, several issues were reported with this strategy...
5.
Malli S, Pomel S, Ayadi Y, Delomenie C, Da Costa A, Loiseau P, et al.
ACS Appl Bio Mater . 2022 Jan; 2(6):2573-2586. PMID: 35030712
Parenteral administration of amphotericin B-deoxycholate (AmB-DOC) or pentavalent antimonials to cure cutaneous leishmaniasis (CL) results in severe adverse reactions, while topically applied antileishmanial drugs are ineffective despite their good tolerance....
6.
Hadji H, Bouchemal K
Adv Drug Deliv Rev . 2022 Jan; 181:114101. PMID: 34999122
The complex pathogenesis of inflammatory bowel disease (IBD) explains the several hurdles for finding an efficient approach to cure it. Nowadays, therapeutic protocols aim to reduce inflammation during the hot...
7.
Hadji H, Bouchemal K
J Control Release . 2022 Jan; 342:93-110. PMID: 34973308
In the drug delivery field, there is beyond doubt that the shape of micro- and nanoparticles (M&NPs) critically affects their biological fate. Herein, following an introduction describing recent technological advances...
8.
Ahmed Z, Ponchel G, Bouchemal K
Int J Pharm . 2021 Oct; 609:121178. PMID: 34662649
The nonspherical shape of nanomaterials (NMs) represents a key attribute for controlling their biological behaviors. Analyzing shape stability over time represents a significant concern because nonspherical NMs are likely to...
9.
Diaz-Salmeron R, Da Costa A, Michel J, Ponchel G, Bouchemal K
Int J Pharm . 2021 Oct; 609:121172. PMID: 34627996
Drug delivery to target sites is often limited by inefficient particle transport through biological media. Herein, motion behaviors of spherical and nonspherical nanomaterials composed of hyaluronic acid were studied in...
10.
Diaz-Salmeron R, Michel J, Hadji H, Gout E, Vives R, Ponchel G, et al.
Colloids Surf B Biointerfaces . 2021 Jun; 205:111916. PMID: 34146785
Increasing valence by acting on nanomaterial morphology can enhance the ability of a ligand to specifically bind to targeted cells. Herein, we investigated cell internalization of soft hyaluronic acid (HA)...